{"organizations": [], "uuid": "3948805401c13153facb49879c4cf75c8bb3eb20", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-essa-pharma-qtrly-loss-per-share-0/brief-essa-pharma-qtrly-loss-per-share-0-07-idUSASB0C5JU", "country": "US", "domain_rank": 408, "title": "BRIEF-Essa Pharma Qtrly Loss Per Share $0.07", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-14T00:11:00.000+02:00", "replies_count": 0, "uuid": "3948805401c13153facb49879c4cf75c8bb3eb20"}, "author": "", "url": "https://www.reuters.com/article/brief-essa-pharma-qtrly-loss-per-share-0/brief-essa-pharma-qtrly-loss-per-share-0-07-idUSASB0C5JU", "ord_in_thread": 0, "title": "BRIEF-Essa Pharma Qtrly Loss Per Share $0.07", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-essa pharma qtrly loss per share", "sentiment": "negative"}, {"name": "reuters st", "sentiment": "negative"}, {"name": "essa pharma inc", "sentiment": "none"}, {"name": "reuters) - essa pharma inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 13 (Reuters) - Essa Pharma Inc:\n* ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS FINANCIAL RESULTS FOR FISCAL FIRST QUARTER ENDED DECEMBER 31, 2017\n* ESSA PHARMA INC - QTRLY LOSS PER SHARE $0.07 Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-14T00:11:00.000+02:00", "crawled": "2018-02-14T00:32:23.066+02:00", "highlightTitle": ""}